Locations

New York, NY, USA

industry

Biotechnology · Data and Analytics · DeepTech · Health · Software

Size

51-200 employees

Stage

Series B

founded in

2019

Immunai is a biotech company that combines single-cell genomics with ML algorithms to enable high-resolution profiling of the immune system. Immunai's mission is to map the entire immune system and its functions using single-cell genomics and machine learning. Immunai leverages single-cell technologies to profile cells from a blood sample, and uses machine-learning algorithms (powered by its proprietary database) to map the hundreds of cell types and their states to create an immune profile. They work on biomarker discovery and insights that identify how a cell responds to its changing environment. .

Something looks off?
Open jobs at Immunai

On-site & Remote